Metabolomics, an analysis of the low molecular weight molecules in cells, tissues or fluids known as metabolites, demonstrated great promise in the early detection, diagnosis, prediction and pharmacodynamic monitoring of therapy. PSA (Prostate Specific Antigen), for example, is considered the most reliable biomarker of prostatic cancer, but its limited specificity results in a large number of false positive cases. Tumor marker is a surrogate indicator that increases or decreases the suspicion of cancer onset, progression, recurrence or response to therapy. Urological cancers in general are detected at a relatively later stage. A key challenge in cancer medicine is to detect cancer at the earliest stage possible.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |